France vs Solomon Islands: Previously treated cases tested for RR-/MDR-TB
France
4.2%
in 2024
Solomon Islands
9.1%
in 2024
France rank
170th
Solomon Islands rank
167th
Previously treated cases tested for RR-/MDR-TB over time
- France
- Solomon Islands
How they compare
Solomon Islands currently reports 9.1% against 4.2% in France, a difference of 4.9%.
That makes Solomon Islands's figure about 2.2 times France's.
The two have swapped places 4 times across 16 shared years of data; in 2006 it was Solomon Islands ahead.
France ranks 170th and Solomon Islands ranks 167th of 180 countries.
Across the 3 decades both report, France averaged higher in 1 and Solomon Islands in 2.
Head to head by decade
| Decade | France | Solomon Islands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 31.0% | 100.0% | 69.0% | Solomon Islands |
| 2010s | 75.8% | 22.7% | 53.1% | France |
| 2020s | 7.8% | 45.2% | 37.4% | Solomon Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, France or Solomon Islands?
- Solomon Islands, at 9.1% against 4.2% in France as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between France and Solomon Islands?
- 4.9%, with Solomon Islands ahead.
- How many years of comparable data are there for France and Solomon Islands?
- 16 years are reported by both, from 2006 to 2024.
- How do France and Solomon Islands rank globally for previously treated cases tested for rr-/mdr-tb?
- France ranks 170th and Solomon Islands ranks 167th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.